Sana Biotechnology Inc [NASDAQ: SANA] stock went on a downward path that fall over -20.97% on Thursday, amounting to a one-week price decrease of less than -23.31%.
Over the last 12 months, SANA stock rose by 22.75%. The one-year Sana Biotechnology Inc stock forecast points to a potential upside of 38.52. The average equity rating for SANA stock is currently 1.67, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $1.66 billion, with 197.86 million shares outstanding and 123.02 million shares in the current float. Compared to the average trading volume of 1.97M shares, SANA stock reached a trading volume of 5685758 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Sana Biotechnology Inc [SANA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SANA shares is $12.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SANA stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Sana Biotechnology Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 16, 2024. While these analysts kept the previous recommendation, JMP Securities raised their target price to Mkt Outperform. The new note on the price target was released on September 25, 2023, representing the official price target for Sana Biotechnology Inc stock. Previously, the target price had yet another raise to $8, while Citigroup analysts kept a Buy rating on SANA stock.
The Average True Range (ATR) for Sana Biotechnology Inc is set at 0.73 The Price to Book ratio for the last quarter was 4.42, with the Price to Cash per share for the same quarter was set at 1.42.
SANA Stock Performance Analysis:
Sana Biotechnology Inc [SANA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.31. With this latest performance, SANA shares dropped by -16.67% in over the last four-week period, additionally plugging by 93.30% over the last 6 months – not to mention a rise of 22.75% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SANA stock in for the last two-week period is set at 37.25, with the RSI for the last a single of trading hit 31.06, and the three-weeks RSI is set at 41.42 for Sana Biotechnology Inc [SANA]. The present Moving Average for the last 50 days of trading for this stock 9.16, while it was recorded at 9.49 for the last single week of trading, and 5.95 for the last 200 days.
Insight into Sana Biotechnology Inc Fundamentals:
Sana Biotechnology Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.07 and a Current Ratio set at 6.07.
Sana Biotechnology Inc [SANA] Institutonal Ownership Details
The top three institutional holders of SANA stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in SANA stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in SANA stock with ownership which is approximately 5.8386%.
